Answers / Financial Due Diligence

Why does the classification of items 'above' versus 'below' the EBITDA line matter so much in QoE, and where do disputes arise?

A core Financial Due Diligence interview question — asked in analyst and associate interviews across IB, PE, and the Big 4.

THE SHORT ANSWER

EBITDA is the headline value driver — the multiple is applied to it — so whether a cost sits above the line (reducing EBITDA) or is excluded as below-the-line or non-operating directly moves price. Disputes cluster around items management wants below the line: recurring 'restructuring', bad-debt write-offs, foreign-exchange losses, gains on asset disposals, and capitalized costs that arguably belong in opex. The discipline is substance and recurrence — a cost that recurs every year, or is integral to running the business, belongs in EBITDA regardless of how it's labelled. I test consistency over time, look for reclassifications between periods that conveniently lift recent EBITDA, and challenge add-backs that lack evidence. Each reclassification at, say, an 8x multiple is worth eight times its annual amount in price, which is why it's contested.

WHAT INTERVIEWERS LISTEN FOR

  • Above/below the line moves EBITDA and hence price (×multiple)
  • Disputes: recurring 'restructuring', FX, disposal gains, capitalization
  • Test substance and recurrence, not the label
  • Watch period-to-period reclassifications

COMMON MISTAKES

  • Accepting labels over substance
  • Allowing recurring costs below the line
  • Missing convenient reclassifications between periods

Reading isn't the same as answering under pressure.

Interviewers don't hand you the model answer — you deliver yours on a clock. Practice this and 1,000+ questions with AI feedback on every answer.

TRY QUICKFIRE →Or train full Financial Due Diligence case simulations →

RELATED QUESTIONS